MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence — Stella

View on ClinicalTrials.gov

Recruiting

Back to Glioma trials

Trial locations(1 site)

China

Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Key details

Sponsor

The First Affiliated Hospital of Zhengzhou University

Collaborators

Sun Yat-sen University

Enrollment target

~3,000 participants

Started

January 2017

Primary completion

January 2027

Age range

1 Year – 95 Years

Last updated February 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.